Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Gross

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Pediatrics|March 1, 1983
Endocarditis in high-risk neonatesD G Oelberg, D J Fisher, D M Gross, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1984
R-enantiomer of timolol: a potential selective ocular antihypertensive agentN N Share, V J Lotti, P Gautheron, et al.
The Journal of Antibiotics|May 1, 1984
Discovery, purification and characterization of the angiotensin converting enzyme inhibitor, L-681,176, produced by Streptomyces sp. MA 5143aL Huang, G Rowin, J Dunn, et al.
Journal of Medicinal Chemistry|July 1, 1983
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole classJ J Baldwin, G H Denny, R Hirschmann, et al.
Contributions to Nephrology|January 1, 1978
A concept for the control of kidney production of erythropoietin involving prostaglandins and cyclic nucleotidesJ W Fisher, D M Gross, J E Foley, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 3, 2008
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantationJ A Bluestone, W Liu, J M Yabu, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitorC S Sweet, D M Gross, P T Arbegast, et al.
Science (New York, N.Y.)|July 31, 1998
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritisD M Gross, T Forsthuber, M Tary-Lehmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivoD M Gross, C S Sweet, E H Ulm, et al.
Journal of Medicinal Chemistry|June 1, 1986
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2J J Baldwin, M E Christy, G H Denny, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Pediatrics|March 1, 1983
Endocarditis in high-risk neonatesD G Oelberg, D J Fisher, D M Gross, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1984
R-enantiomer of timolol: a potential selective ocular antihypertensive agentN N Share, V J Lotti, P Gautheron, et al.
The Journal of Antibiotics|May 1, 1984
Discovery, purification and characterization of the angiotensin converting enzyme inhibitor, L-681,176, produced by Streptomyces sp. MA 5143aL Huang, G Rowin, J Dunn, et al.
Journal of Medicinal Chemistry|July 1, 1983
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole classJ J Baldwin, G H Denny, R Hirschmann, et al.
Contributions to Nephrology|January 1, 1978
A concept for the control of kidney production of erythropoietin involving prostaglandins and cyclic nucleotidesJ W Fisher, D M Gross, J E Foley, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 3, 2008
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantationJ A Bluestone, W Liu, J M Yabu, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitorC S Sweet, D M Gross, P T Arbegast, et al.
Science (New York, N.Y.)|July 31, 1998
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritisD M Gross, T Forsthuber, M Tary-Lehmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivoD M Gross, C S Sweet, E H Ulm, et al.
Journal of Medicinal Chemistry|June 1, 1986
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2J J Baldwin, M E Christy, G H Denny, et al.
Pageof 6